MATAWAN, N.J. & MOSCOW, Idaho, November 10, 2025--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ("Apimeds") today announced the expansion of its ai² Futures Lab™ program ...
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business Apimeds Pharmaceuticals US, Inc. (NYSE: ...